Trials / Completed
CompletedNCT02853422
Quality-Of-Life QLQ-GINET21 Questionnaire In The Treatment Of Patients With Gastrointestinal Neuroendocrine Tumours
A Study Evaluating The Clinical Utility Of The Health-Related Quality-Of-Life QLQ-GINET21 Questionnaire In The Treatment Of Patients With Gastrointestinal Neuroendocrine Tumours QUALINETS Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 199 (actual)
- Sponsor
- Ipsen · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the utility of the QLQ-GINET21 in making clinical and therapeutic decisions.
Conditions
Timeline
- Start date
- 2016-04-01
- Primary completion
- 2017-01-01
- Completion
- 2017-01-01
- First posted
- 2016-08-02
- Last updated
- 2020-11-05
Locations
32 sites across 2 countries: Portugal, Spain
Source: ClinicalTrials.gov record NCT02853422. Inclusion in this directory is not an endorsement.